Print

Teva Pharmaceutical Industries Limited (TEVA) Announces Launch of Generic Prometrium® Capsules in the United States  
3/2/2012 6:51:16 AM

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today the commercial launch of Progesterone Capsules, 100 & 200 mg, the AB-rated generic equivalent of Abbott Laboratories’ Prometrium® Capsules.
//-->